According to @CNBC, UBS turned bearish on Rivian and said the stock’s valuation looks stretched following a recent rally. CNBC did not include rating specifics, a price target, or any direct cryptocurrency market implications in the post.

According to Stock Talk (@stocktalkweekly), a major stock was recently downgraded while its price target was simultaneously raised by $110, indicating a nuanced analyst outlook (source: Twitter, June 16, 2025). For equity traders, this mixed signal often suggests volatility ahead, as institutional sentiment is divided between longer-term valuation and short-term performance. For crypto traders, such events can impact sentiment, especially if the stock is tech-related or has historical correlation with digital assets. Monitoring market reaction in both equities and correlated cryptocurrencies is recommended.

According to Stock Talk (@stocktalkweekly), Bank of America has reiterated its 'Underperform' rating on Hims & Hers Health ($HIMS) with a $28 price target due to a reported total sales decline in April, as cited by analyst Michael Cherny. This downgrade and sales weakness may signal increased risk sentiment for growth stocks, which could influence crypto market positioning, as traders often rotate between tech equities and digital assets based on risk appetite (source: Stock Talk on Twitter, May 22, 2025).